{
    "2018-08-23": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Pfizer Amends Xtandi Study Protocols to Speed Up Completion",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xtandi",
                        "Study",
                        "Protocols",
                        "Speed Up",
                        "Completion"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "J&J to Appeal as Judge Confirms Jury Order in Talc Case",
                "features": {
                    "keywords": [
                        "J&J",
                        "Appeal",
                        "Judge",
                        "Jury",
                        "Order",
                        "Talc",
                        "Case"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio",
                "features": {
                    "keywords": [
                        "Large-Cap",
                        "Pharma",
                        "Rebounds",
                        "Stocks",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Xtandi Trials: Pfizer and Astella Amend the Protocols",
                "features": {
                    "keywords": [
                        "Xtandi",
                        "Trials",
                        "Pfizer",
                        "Astella",
                        "Amend",
                        "Protocols"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-15",
                "original_text": "How Incyteâ€™s Product Portfolio Is Looking in August",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Product",
                        "Portfolio",
                        "August"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}